Drugs / MK1903
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00847197 | Jun 2008 → Sep 2009 | hyperlipidemia | Merck Sharp & Dohme LLC | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK1903 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00847197 ↗ |
| Route | Oral | “by mouth” NCT00847197 ↗ |